SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-023840
Filing Date
2021-02-16
Accepted
2021-02-16 16:00:51
Documents
2
Group Members
DALIA BLEYERNEXTECH V GP S.A R.L.THOMAS LIPS

Document Format Files

Seq Description Document Type Size
1 SC 13G tm216872d2_sc13g.htm SC 13G 88846
2 EXHIBIT 99.1 tm216872d2_ex99-1.htm EX-99.1 7408
  Complete submission text file 0001104659-21-023840.txt   97821
Mailing Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748
Business Address 7, RUE LOU HEMMER LUXEMBOURG-FINDEL N4 L-1748 352-246-160-6000
Nextech V Oncology S.C.S., SICAV-SIF (Filed by) CIK: 0001712922 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Subject) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91893 | Film No.: 21637710
SIC: 2834 Pharmaceutical Preparations